BI 409306 for Alzheimers Disease or Schizophrenia

Language
Undefined

Purpose: To test the experimental drug BI 409306 in people with Alzheimer's disease or schizophrenia and in healthy volunteers.

Source: Alzheimers Clinical Trials - October 19, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials